{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:03:57Z","timestamp":1780322637336,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia","award":["IPP: 340-166-2025"],"award-info":[{"award-number":["IPP: 340-166-2025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05034-9","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T12:48:49Z","timestamp":1776516529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous paclitaxel delivered by a vitamin E nanocarrier as a safe and economical alternative to albumin-bound nanoparticles"],"prefix":"10.1007","volume":"17","author":[{"given":"Amerh A.","family":"Alahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab M. M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Aljagthmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"5034_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262.","journal-title":"CA Cancer J Clin"},{"key":"5034_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jncc.2025.02.002","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji Y, Liu S, Li J, Wu J, Jin Q, et al. Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J Natl Cancer Cent. 2025;5:287\u201396. https:\/\/doi.org\/10.1016\/j.jncc.2025.02.002.","journal-title":"J Natl Cancer Cent"},{"key":"5034_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100131","author":"R Ahmed","year":"2022","unstructured":"Ahmed R, Samanta S, Banerjee J, Kar SS, Dash SK. Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation. Curr Res Pharmacol Drug Discovery. 2022. https:\/\/doi.org\/10.1016\/j.crphar.2022.100131. 3.","journal-title":"Curr Res Pharmacol Drug Discovery"},{"key":"5034_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/CAAC.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438\u201351. https:\/\/doi.org\/10.3322\/CAAC.21583.","journal-title":"CA Cancer J Clin"},{"key":"5034_CR5","doi-asserted-by":"publisher","unstructured":"Gradishar WJ. Taxanes for the treatment of metastatic breast cancer. Breast Cancer (Auckl). 2012;6. https:\/\/doi.org\/10.4137\/BCBCR.S8205.","DOI":"10.4137\/BCBCR.S8205"},{"key":"5034_CR6","doi-asserted-by":"publisher","unstructured":"Gelderblom H, Verweij J, Nooter K, Sparreboom A, Cremophor EL. The drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001;37. https:\/\/doi.org\/10.1016\/S0959-8049(01)00171-X.","DOI":"10.1016\/S0959-8049(01)00171-X"},{"key":"5034_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/S11094-021-02526-6\/METRICS","volume":"55","author":"A Sadeghi-Oroumiyeh","year":"2021","unstructured":"Sadeghi-Oroumiyeh A, Valizadeh H, Zakeri-Milani P. Determination of Paclitaxel Solubility and Stability in the Presence of Injectable Excipients. Pharm Chem J. 2021;55:983\u20137. https:\/\/doi.org\/10.1007\/S11094-021-02526-6\/METRICS.","journal-title":"Pharm Chem J"},{"key":"5034_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/S12248-012-9339-4","volume":"14","author":"N Desai","year":"2012","unstructured":"Desai N. Challenges in Development of Nanoparticle-Based Therapeutics. AAPS J. 2012;14:282. https:\/\/doi.org\/10.1208\/S12248-012-9339-4.","journal-title":"AAPS J"},{"key":"5034_CR9","doi-asserted-by":"publisher","unstructured":"Strickley RG. Solubilizing Excipients in Oral and Injectable Formulations. Pharm Res. 2004;21. https:\/\/doi.org\/10.1023\/B:PHAM.0000016235.32639.23.","DOI":"10.1023\/B:PHAM.0000016235.32639.23"},{"key":"5034_CR10","doi-asserted-by":"publisher","unstructured":"Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm. 2002;235. https:\/\/doi.org\/10.1016\/S0378-5173(01)00986-3.","DOI":"10.1016\/S0378-5173(01)00986-3"},{"key":"5034_CR11","doi-asserted-by":"publisher","unstructured":"Kan P, Chen ZB, Lee CJ, Chu IM. Development of nonionic surfactant\/phospholipid o\/w emulsion as a paclitaxel delivery system. J Controlled Release 1999;58. https:\/\/doi.org\/10.1016\/S0168-3659(98)00164-3","DOI":"10.1016\/S0168-3659(98)00164-3"},{"key":"5034_CR12","doi-asserted-by":"publisher","unstructured":"Alcaro S, Ventura CA, Paolino D, Battaglia D, Ortuso F, Cattel L et al. Preparation, characterization, molecular modeling and in vitro activity of paclitaxel-cyclodextrin complexes. Bioorg Med Chem Lett 2002;12. https:\/\/doi.org\/10.1016\/S0960-894X(02)00217-2","DOI":"10.1016\/S0960-894X(02)00217-2"},{"key":"5034_CR13","doi-asserted-by":"publisher","unstructured":"Yang T, Cui F, De, Choi MK, Cho JW, Chung SJ, Shim CK, et al. Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation. Int J Pharm. 2007;338. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.02.011.","DOI":"10.1016\/j.ijpharm.2007.02.011"},{"key":"5034_CR14","doi-asserted-by":"publisher","unstructured":"Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Controlled Release. 2000;63. https:\/\/doi.org\/10.1016\/S0168-3659(99)00166-2.","DOI":"10.1016\/S0168-3659(99)00166-2"},{"key":"5034_CR15","doi-asserted-by":"publisher","unstructured":"Cavalli R, Caputo O, Gasco MR. Preparation and characterization of solid lipid nanospheres containing paclitaxel. Eur J Pharm Sci. 2000;10. https:\/\/doi.org\/10.1016\/S0928-0987(00)00081-6.","DOI":"10.1016\/S0928-0987(00)00081-6"},{"key":"5034_CR16","doi-asserted-by":"publisher","unstructured":"Chen DB, Yang TZ, Lu WL, Zhang Q. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem Pharm Bull (Tokyo). 2001;49. https:\/\/doi.org\/10.1248\/cpb.49.1444.","DOI":"10.1248\/cpb.49.1444"},{"key":"5034_CR17","doi-asserted-by":"publisher","unstructured":"Haddad R, Alrabadi N, Altaani B, Li T. Paclitaxel Drug Delivery Systems: Focus on Nanocrystals\u2019 Surface Modifications. Polym (Basel). 2022;14. https:\/\/doi.org\/10.3390\/polym14040658.","DOI":"10.3390\/polym14040658"},{"key":"5034_CR18","doi-asserted-by":"publisher","unstructured":"Danhier F, Lecouturier N, Vroman B, J\u00e9r\u00f4me C, Marchand-Brynaert J, Feron O, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Controlled Release. 2009;133. https:\/\/doi.org\/10.1016\/j.jconrel.2008.09.086.","DOI":"10.1016\/j.jconrel.2008.09.086"},{"key":"5034_CR19","doi-asserted-by":"publisher","unstructured":"Bernabeu E, Helguera G, Legaspi MJ, Gonzalez L, Hocht C, Taira C, et al. Paclitaxel-loaded PCL-TPGS nanoparticles: In vitro and in vivo performance compared with Abraxane\u00ae. Colloids Surf B Biointerfaces. 2014;113. https:\/\/doi.org\/10.1016\/j.colsurfb.2013.07.036.","DOI":"10.1016\/j.colsurfb.2013.07.036"},{"key":"5034_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/10717544.2018.1455763","volume":"25","author":"W Li","year":"2018","unstructured":"Li W, Wu J, Zhang J, Wang J, Xiang D, Luo S, et al. Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. Drug Deliv. 2018;25:827\u201337. https:\/\/doi.org\/10.1080\/10717544.2018.1455763.","journal-title":"Drug Deliv"},{"key":"5034_CR21","doi-asserted-by":"publisher","unstructured":"Zhang W, Shi Y, Chen Y, Hao J, Sha X, Fang X. The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials. 2011;32. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.04.075.","DOI":"10.1016\/j.biomaterials.2011.04.075"},{"key":"5034_CR22","doi-asserted-by":"publisher","unstructured":"Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, et al. Paclitaxel-loaded Pluronic P123\/F127 mixed polymeric micelles: Formulation, optimization and in vitro characterization. Int J Pharm. 2009;376. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.04.030.","DOI":"10.1016\/j.ijpharm.2009.04.030"},{"key":"5034_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-813627-0.00009-0","author":"J Sobczy\u0144ski","year":"2018","unstructured":"Sobczy\u0144ski J, Chudzik-Rz\u0105d B. Mixed micelles as drug delivery nanocarriers. Des Dev New Nanocarriers. 2018. https:\/\/doi.org\/10.1016\/B978-0-12-813627-0.00009-0.","journal-title":"Des Dev New Nanocarriers"},{"key":"5034_CR24","doi-asserted-by":"publisher","unstructured":"Yu L, Bridgers A, Polli J, Vickers A, Long S, Roy A, et al. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res. 1999;16. https:\/\/doi.org\/10.1023\/A:1018939006780.","DOI":"10.1023\/A:1018939006780"},{"key":"5034_CR25","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1021\/MP500384D","volume":"11","author":"Y Bao","year":"2014","unstructured":"Bao Y, Guo Y, Zhuang X, Li D, Cheng B, Tan S, et al. D-\u03b1-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm. 2014;11:3196\u2013209. https:\/\/doi.org\/10.1021\/MP500384D.","journal-title":"Mol Pharm"},{"key":"5034_CR26","doi-asserted-by":"publisher","DOI":"10.1385\/1592594069","author":"SP Langdon","year":"2003","unstructured":"Langdon SP. Cancer Cell Culture. Cancer Cell Cult. 2003. https:\/\/doi.org\/10.1385\/1592594069.","journal-title":"Cancer Cell Cult"},{"key":"5034_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1083\/JCB.71.1.172","volume":"71","author":"J Fried","year":"1976","unstructured":"Fried J, Perez AG, Clarkson BD. Flow cytofluorometric analysis of cell cycle distributions using propidium iodide. Properties of the method and mathematical analysis of the data. J Cell Biol. 1976;71:172\u201381. https:\/\/doi.org\/10.1083\/JCB.71.1.172.","journal-title":"J Cell Biol"},{"key":"5034_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0165-2478(01)00226-7","volume":"78","author":"E Derby","year":"2001","unstructured":"Derby E, Reddy V, Kopp W, Nelson E, Baseler M, Sayers T, et al. Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity. Immunol Lett. 2001;78:35\u20139. https:\/\/doi.org\/10.1016\/S0165-2478(01)00226-7.","journal-title":"Immunol Lett"},{"key":"5034_CR29","doi-asserted-by":"publisher","unstructured":"Al-Zahrani NS, Zamzami MA, Baghdadi MA, El-Gowily AH, Ali EMM, Al-Zahrani NS et al. Regulation of Protein-Induced Apoptosis and Autophagy in Human Hepatocytes Treated with Metformin and Paclitaxel In Silico and In Vitro. Biomedicines 2023, Vol 11, Page 2688. 2023;11:2688. https:\/\/doi.org\/10.3390\/BIOMEDICINES11102688","DOI":"10.3390\/BIOMEDICINES11102688"},{"key":"5034_CR30","doi-asserted-by":"publisher","unstructured":"Chen G, Yang Y, Xu C, Gao S. A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia\/Reoxygenation. J Vis Exp. 2018;2018. https:\/\/doi.org\/10.3791\/57725.","DOI":"10.3791\/57725"},{"key":"5034_CR31","doi-asserted-by":"publisher","unstructured":"Feng C, Wang Y, Xu J, Zheng Y, Zhou W, Wang Y et al. Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect. Pharmaceutics 2024, Vol 16, 2024;16. https:\/\/doi.org\/10.3390\/pharmaceutics16121582","DOI":"10.3390\/pharmaceutics16121582"},{"key":"5034_CR32","doi-asserted-by":"publisher","unstructured":"Yuan H, Chen Y, Hu Y, Wang Y, Luo C, Chen, Yao et al. Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy. J Pharm Investig. 2025;55:889\u2013902. https:\/\/doi.org\/10.1007\/s40005-025-00731-z","DOI":"10.1007\/s40005-025-00731-z"},{"key":"5034_CR33","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/jps.10154","volume":"91","author":"MJ Akers","year":"2002","unstructured":"Akers MJ. Excipient-drug interactions in parenteral formulations. J Pharm Sci. 2002;91:2283\u2013300. https:\/\/doi.org\/10.1002\/jps.10154.","journal-title":"J Pharm Sci"},{"key":"5034_CR34","first-page":"152","volume":"54","author":"RG Strickley","year":"2000","unstructured":"Strickley RG. Parenteral formulations of small molecules therapeutics marketed in the United States (1999) Part III. PDA J Pharm Sci Technol. 2000;54:152\u201369.","journal-title":"PDA J Pharm Sci Technol"},{"key":"5034_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/623139","volume":"2012","author":"MS Surapaneni","year":"2012","unstructured":"Surapaneni MS, Das SK, Das NG. Designing Paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges. ISRN Pharmacol. 2012;2012:1\u201315. https:\/\/doi.org\/10.5402\/2012\/623139.","journal-title":"ISRN Pharmacol"},{"key":"5034_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","volume":"21","author":"RG Strickley","year":"2004","unstructured":"Strickley RG. Solubilizing Excipients in Oral and Injectable Formulations. Pharm Res. 2004;21:201\u201330. https:\/\/doi.org\/10.1023\/B:PHAM.0000016235.32639.23.","journal-title":"Pharm Res"},{"key":"5034_CR37","doi-asserted-by":"publisher","unstructured":"Mehata AK, Setia A, Vikas, Malik AK, Hassani R, Dailah HG et al. Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future. Pharmaceutics 2023;15. https:\/\/doi.org\/10.3390\/pharmaceutics15030722","DOI":"10.3390\/pharmaceutics15030722"},{"key":"5034_CR38","doi-asserted-by":"publisher","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics 2018. Page. 57 2018;10:10:57. https:\/\/doi.org\/10.3390\/PHARMACEUTICS10020057.","DOI":"10.3390\/PHARMACEUTICS10020057"},{"key":"5034_CR39","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.powtec.2020.07.093","volume":"375","author":"S Sotthivirat","year":"2020","unstructured":"Sotthivirat S, Ramesh R, Wasylaschuk W, Bottone C, Xia B, Stellabott J, et al. Effect of TPGS surfactant on dissolution sensitivity of a poorly water-soluble drug using high-shear wet granulation. Powder Technol. 2020;375:302\u20139. https:\/\/doi.org\/10.1016\/j.powtec.2020.07.093.","journal-title":"Powder Technol"},{"key":"5034_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/NAN.0000000000000194","volume":"39","author":"JW Spray","year":"2016","unstructured":"Spray JW. Review of intravenous lipid emulsion therapy. J Infus Nurs. 2016;39:377\u201380. https:\/\/doi.org\/10.1097\/NAN.0000000000000194.","journal-title":"J Infus Nurs"},{"key":"5034_CR41","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1080\/10717544.2017.1406561","volume":"24","author":"S Tan","year":"2017","unstructured":"Tan S, Zou C, Zhang W, Yin M, Gao X, Tang Q. Recent developments in d -\u03b1-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv. 2017;24:1831\u201342. https:\/\/doi.org\/10.1080\/10717544.2017.1406561.","journal-title":"Drug Deliv"},{"key":"5034_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7150\/thno.22711","volume":"8","author":"C Yang","year":"2018","unstructured":"Yang C, Wu T, Qi Y, Zhang Z. Recent Advances in the Application of Vitamin E TPGS for Drug Delivery. Theranostics. 2018;8:464\u201385. https:\/\/doi.org\/10.7150\/thno.22711.","journal-title":"Theranostics"},{"key":"5034_CR43","doi-asserted-by":"publisher","unstructured":"Tang L, Huang K, Jiang W, Fu L, Zhang R, Shen L, et al. Exploration of the inhibition action of TPGS on tumor cells and its combined use with chemotherapy drugs. Drug Deliv. 2023;30. https:\/\/doi.org\/10.1080\/10717544.2023.2183830.","DOI":"10.1080\/10717544.2023.2183830"},{"key":"5034_CR44","doi-asserted-by":"publisher","first-page":"1000164","DOI":"10.4172\/2157-7439.1000164","volume":"4","author":"P Ma","year":"2013","unstructured":"Ma P, Mumper RJ. Paclitaxel Nano-Delivery Systems: A Comprehensive Review. J Nanomed Nanotechnol. 2013;4:1000164. https:\/\/doi.org\/10.4172\/2157-7439.1000164.","journal-title":"J Nanomed Nanotechnol"},{"key":"5034_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.chemphyslip.2018.03.005","volume":"213","author":"SM Han","year":"2018","unstructured":"Han SM, Baek JS, Kim MS, Hwang SJ, Cho CW. Surface modification of paclitaxel-loaded liposomes using d-\u03b1-tocopheryl polyethylene glycol 1000 succinate: Enhanced cellular uptake and cytotoxicity in multidrug resistant breast cancer cells. Chem Phys Lipids. 2018;213:39\u201347. https:\/\/doi.org\/10.1016\/j.chemphyslip.2018.03.005.","journal-title":"Chem Phys Lipids"},{"key":"5034_CR46","doi-asserted-by":"publisher","first-page":"19736","DOI":"10.1021\/ACSAMI.1C03065","volume":"13","author":"M Hama","year":"2021","unstructured":"Hama M, Ishima Y, Chuang VTG, Ando H, Shimizu T, Ishida T. Evidence for Delivery of Abraxane via a Denatured-Albumin Transport System. ACS Appl Mater Interfaces. 2021;13:19736\u201344. https:\/\/doi.org\/10.1021\/ACSAMI.1C03065.","journal-title":"ACS Appl Mater Interfaces"},{"key":"5034_CR47","doi-asserted-by":"publisher","unstructured":"Ahmed TA, Ali EMM, Kalantan AA, Almehmady AM, El-Say KM. Exploring the Enhanced Antiproliferative Activity of Turmeric Oil and 6-Mercaptopurine in a Combined Nano-Particulate System Formulation. Pharmaceutics 2023;15. https:\/\/doi.org\/10.3390\/pharmaceutics15071901","DOI":"10.3390\/pharmaceutics15071901"},{"key":"5034_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/JAPTR.JAPTR_26_20","volume":"11","author":"GES Chaudhry","year":"2020","unstructured":"Chaudhry GES, Akim A, Zafar M, Abdullah M, Sung Y, Muhammad T. Induction of apoptosis and role of paclitaxel-loaded hyaluronic acid-crosslinked nanoparticles in the regulation of AKT and RhoA. J Adv Pharm Technol Res. 2020;11:101. https:\/\/doi.org\/10.4103\/JAPTR.JAPTR_26_20.","journal-title":"J Adv Pharm Technol Res"},{"key":"5034_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.colsurfb.2016.01.003","volume":"140","author":"E Bernabeu","year":"2016","unstructured":"Bernabeu E, Gonzalez L, Cagel M, Gergic EP, Moretton MA, Chiappetta DA. Novel Soluplus\u00ae-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloids Surf B Biointerfaces. 2016;140:403\u201311. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.01.003.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"5034_CR50","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.17219\/ACEM\/127681","volume":"29","author":"G Li","year":"2020","unstructured":"Li G, Xu D, Sun J, Zhao S, Zheng D. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K\/AKT signaling pathway. Adv Clin Exp Med. 2020;29:1337\u201345. https:\/\/doi.org\/10.17219\/ACEM\/127681.","journal-title":"Adv Clin Exp Med"},{"key":"5034_CR51","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.lfs.2004.09.021","volume":"76","author":"PC Liao","year":"2005","unstructured":"Liao PC, Lieu CH. Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells. Life Sci. 2005;76:1623\u201339. https:\/\/doi.org\/10.1016\/j.lfs.2004.09.021.","journal-title":"Life Sci"},{"key":"5034_CR52","doi-asserted-by":"publisher","first-page":"102278","DOI":"10.1016\/j.mtbio.2025.102278","volume":"35","author":"X Wang","year":"2025","unstructured":"Wang X, Sun K, Dong J, Ge Y, Liu H, Jin X, et al. Carrier-free nanoparticles based on natural products trigger dual synergy and attenuation for enhanced phototherapy of liver cancer. Mater Today Bio. 2025;35:102278. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102278.","journal-title":"Mater Today Bio"},{"key":"5034_CR53","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1074\/JBC.M106802200","volume":"277","author":"JF Kidd","year":"2002","unstructured":"Kidd JF, Pilkington MF, Schell MJ, Fogarty KE, Skepper JN, Taylor CW, et al. Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. J Biol Chem. 2002;277:6504\u201310. https:\/\/doi.org\/10.1074\/JBC.M106802200.","journal-title":"J Biol Chem"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05034-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05034-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05034-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:02:16Z","timestamp":1780318936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05034-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5034"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05034-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"823"}}